Edition:
United States

Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

299.82USD
15 Feb 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$299.82
Open
--
Day's High
--
Day's Low
--
Volume
3
Avg. Vol
1,166,502
52-wk High
$372.61
52-wk Low
$221.49

Chart for

About

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of... (more)

Overall

Beta: 1.15
Market Cap(Mil.): $44,073.54
Shares Outstanding(Mil.): 147.00
Dividend: --
Yield (%): --

Financials

  ILMN.O Industry Sector
P/E (TTM): 53.46 70.14 35.99
EPS (TTM): 5.61 -- --
ROI: 17.06 6.20 12.72
ROE: 25.73 8.74 13.73

Illumina to buy rival Pacific Biosciences in $1.2 billion deal

Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion, expanding its capabilities as the market grows.

Nov 01 2018

UPDATE 1-Illumina to buy rival Pacific Biosciences in $1.2 bln deal

Nov 1 Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion, expanding its capabilities as the market grows.

Nov 01 2018

Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 bln deal

Nov 1 Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion.

Nov 01 2018

Earnings vs. Estimates